glp-1 obesity drug news oct 21 2025 Why Non-Responders Need Earlier Anti-Obesity Medication Intervention GlobalRPH New GLP-1 Pill Foundayo (Orforglipron)
Description
Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity
This is not just about neuroprotection
Patients should be referred to health coaches, dietitians, physiotherapists, or online weight management programmes for additional support
The risk of multiple myeloma was 41% lower in those taking GLP-1 drugs compared to insulin
